I joined the Garnett group in late 2020 as an Advanced Research Assistant, where I derived novel organoids and supported research identifying and characterising genetic vulnerabilities of various cancers. I transitioned into my role as a Cellular Screening Specialist in earlier 2022, where I became much more involved in the high throughput drug screening of cell and organoid lines. I also have a role in lab management and health and safety within the team. More recently I have been leading the setup of a new project investigating molecular glues.
Before I came to Sanger I undertook a PhD at the University of Leicester investigating novel regulators of telomere length in human cells, and completed an undergraduate degree in Biomedical Sciences at Cardiff University.